These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28818638)

  • 1. Association of hemoglobin A1c variability and the incidence of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and arterial hypertension.
    Gu J; Fan YQ; Zhang JF; Wang CQ
    Hellenic J Cardiol; 2018; 59(2):91-97. PubMed ID: 28818638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of glycemic variability with left ventricular diastolic function in type 2 diabetes mellitus.
    Yokota S; Tanaka H; Mochizuki Y; Soga F; Yamashita K; Tanaka Y; Shono A; Suzuki M; Sumimoto K; Mukai J; Suto M; Takada H; Matsumoto K; Hirota Y; Ogawa W; Hirata KI
    Cardiovasc Diabetol; 2019 Dec; 18(1):166. PubMed ID: 31805945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: A retrospective observational cohort study.
    Gu J; Fan YQ; Bian L; Zhang HL; Xu ZJ; Zhang Y; Chen QZ; Yin ZF; Xie YS; Wang CQ
    Eur J Prev Cardiol; 2016 Sep; 23(13):1421-8. PubMed ID: 26915580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus.
    Gu J; Pan JA; Fan YQ; Zhang HL; Zhang JF; Wang CQ
    Cardiovasc Diabetol; 2018 Jun; 17(1):96. PubMed ID: 29960591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac Structural and Functional Features in Patients With Type 2 Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction:A Study Based on Propensity Score Matching].
    Peng KL; Liu YM; Jia XY; Wang H; Gou CL; Xue LL; Zou Q; Zhang WJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):264-272. PubMed ID: 37157074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do we need biomarkers for diabetics progressing to heart failure?
    Dimitriadis K; Tsioufis C; Tousoulis D
    Hellenic J Cardiol; 2018; 59(2):98-99. PubMed ID: 29940223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic control and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: insight from ventricular remodeling using cardiac MRI.
    Shi K; Zhang G; Fu H; Li XM; Gao Y; Shi R; Xu HY; Li Y; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2024 Apr; 23(1):148. PubMed ID: 38685007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.
    Lejeune S; Roy C; Slimani A; Pasquet A; Vancraeynest D; Vanoverschelde JL; Gerber BL; Beauloye C; Pouleur AC
    Cardiovasc Diabetol; 2021 Feb; 20(1):48. PubMed ID: 33608002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension.
    Gu J; Yin ZF; Zhang JF; Wang CQ
    Int J Cardiol; 2020 May; 306():140-145. PubMed ID: 31711850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between long-term prescription of aldosterone antagonist and the progression of heart failure with preserved ejection fraction in hypertensive patients.
    Gu J; Fan YQ; Han ZH; Fan L; Bian L; Zhang HL; Xu ZJ; Yin ZF; Xie YS; Zhang JF; Wang CQ
    Int J Cardiol; 2016 Oct; 220():56-60. PubMed ID: 27372043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin A1c in type 2 diabetes mellitus patients with preserved ejection fraction is an independent predictor of left ventricular myocardial deformation and tissue abnormalities.
    Li Z; Han D; Qi T; Deng J; Li L; Gao C; Gao W; Chen H; Zhang L; Chen W
    BMC Cardiovasc Disord; 2023 Jan; 23(1):49. PubMed ID: 36698087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation analysis of the triglyceride glucose index and heart failure with preserved ejection fraction in essential hypertensive patients.
    Liao LP; Yang Y; Wu Y; Li W
    Clin Cardiol; 2022 Sep; 45(9):936-942. PubMed ID: 35770315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes.
    Kristensen SL; Jhund PS; Lee MMY; Køber L; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; McMurray JJV;
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):545-549. PubMed ID: 28948430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of chronic heart failure with preserved left ventricular ejection fraction in patients with hypertension and isolated mild diastolic dysfunction.
    Brzyżkiewicz H; Konduracka E; Gajos G; Janion M
    Pol Arch Med Wewn; 2016; 126(1-2):12-8. PubMed ID: 26810565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction.
    Zhang L; Liebelt JJ; Madan N; Shan J; Taub CC
    Am J Cardiol; 2017 Jun; 119(11):1815-1820. PubMed ID: 28450040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of advanced liver fibrosis with heart failure with preserved ejection fraction in type 2 diabetic patients according to obesity and metabolic goal achievement status.
    Jiang W; Liu Z; Liu S; Du T
    Front Endocrinol (Lausanne); 2023; 14():1183075. PubMed ID: 37941902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
    Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
    Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Can a lipophilic statin improve the treatment of heart failure with preserved ejection fraction in patients with hypertension and obesity?].
    Vasyuk YA; Shupenina EY; Namazova GA; Zavyalova AI
    Kardiologiia; 2023 Nov; 63(10):47-54. PubMed ID: 37970855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.